CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

The coverage change only applies to employer and union insurance plans ... Wegovy will enable more employers to provide coverage for the weight loss category," CVS Health Vice President of External ...

CVS Health, owner of Aetna, announced that Aetna will withdraw all Affordable Care Act (ACA) individual and family plans at ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay programs at $499 monthly ...

NEW YORK, July 14 (Reuters) - President Donald Trump's spending bill is set to raise administrative costs and make managing ...

The coverage change applies to CVS Caremark’s most common formulary template, which represents between 25 and 30 million individuals overall. ... CVS Health said.

Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success.

Now she fears a deal struck between CVS Health Corp. and Novo Nordisk A/S will undo all that progress. Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood ...